My name is Nov Sokha. I am 61 years old.

The first time I felt sick, I went to the hospital.

I wanted to know why I always felt exhausted.

They diagnosed me with hepatitis C.

I felt really worried.

I didn't know what to do.

I saw some people get treated but I couldn't afford the medicines.

I just tried to ignore it.

Since September 2016 MSF's clinic in Phnom Penh has been offering free treatment for people with hepatitis C,

using a more effective easier to use pill-only treatment.

Nov has been regularly visiting the clinic for checkups,

and hopes she will be put on the new treatment soon.

When I went to the clinic,

I saw people who got the medicine

and they told me they got cured.

They said they got their strength back.

It made me happy to hear that,

and I hope that MSF is able to cure me.

Nowadays, I feel very tired.

I've been feeling tired for 20 years.

Maybe I'll feel happy afterwards.

Like when I was younger.

That's what I thought this morning.

Maybe I'll have more energy.

I hate and am disgusted with hepatitis C.

It's given me a really hard time,

and caused me lots of pain.

Sometimes it makes me feel mad

for no reason.

I have relatives living in America and France.

They wanted to buy me a plane ticket

but now, if I go, I'm afraid I'll spread the disease.

I'm afraid of that everyday.

That's why I don't let anybody know,

I'm afraid they'll be disgusted with me.

Shortly after our visit, Nov started the new treatment at the MSF clinic

and recently received the all clear.

MSF has been working to knock down the price of new hepatitis C medicines.

As a result it now costs MSF US$120 to treat someone with hepatitis C in some of the countries where we work.

That's more than 1000 times less than the original launch price.

The reduced price means we are able to put more people in our projects on treatment.

Much more needs to happen so everyone living with hepatitis C gets the medicines they need.

Find out how we're changing that: Msfaccess.org.

With thanks to the MSF team and patients in MSF's Phnom Penh hepatitis C project.